Seasonal Influenza Vaccines 2026/2027
A Contract Award Notice
by REGIONAL BUSINESS SERVICES ORGANISATION, PROCUREMENT AND LOGISTICS SERVICE
- Source
- Find a Tender
- Type
- Contract (Supply)
- Duration
- 10 year (est.)
- Value
- £5M
- Sector
- HEALTH
- Published
- 21 May 2026
- Delivery
- To 20 May 2036 (est.)
- Deadline
- n/a
Related Terms
Location
Belfast
2 buyers
1 supplier
- Seqirus Maidenhead
Description
This contract is for the procurement of Seasonal Influenza Vaccines for the population of Northern Ireland
Total Quantity or Scope
Contract 6100211 is established under the Medicinal Products Dynamic Purchasing System (131864). This contract is for Seasonal Influenza vaccines for the population of Northern Ireland.
Award Detail
| 1 | Seqirus (Maidenhead)
|
Award Criteria
| All Categories (A, B, C, D): Compliance with Contract Scope and Specification / Weighting: | _ |
| All Categories (A, B, C, D): Registration on the NHS Evergreen Sustainable Supplier Assessment platform | _ |
| All Categories (A, B, C, D): Supply and Delivery of Product (GDP Compliance) | _ |
| All Categories (A, B, C, D): Governance, Quality Control and Risk (PQA Section 1) | _ |
| All Categories (A, B, C, D): Governance, Quality Control and Risk (PQA Section 2-6) | 10.0 |
| Categories A & B only: Governance, Quality Control and Risk (Safety Engineered Protective Needle) | 10.0 |
| Categories C & D only: Governance, Quality Control and Risk (Safety Engineered Protective Needle) | 4.0 |
| Categories A & B only: Product Makeup (Ovalbumin Content) | 10.0 |
| All Categories (A, B, C, D): Product Makeup (Formaldehyde Content) | 1.0 |
| All Categories (A, B, C, D): Product Makeup (Latex Status/Threat) | 1.0 |
| All Categories (A, B, C, D): Supporting Information (Availability of PILs) | 3.0 |
| All Categories (A, B, C, D): Supply and Delivery of Product (Delivery Timescales) | 25.0 |
| Categories C & D only: Product Licence (Age Group Coverage) | 16.0 |
| Price | 40.0 |
CPV Codes
- 33600000 - Pharmaceutical products
Indicators
- Award on basis of price and quality.
Other Information
The figure in V.2.4 is the awarded figure based on volume of doses agreed at the time of tender award. However, should there be a requirement for additional volumes, the Authority reserves the right to purchase further volumes up to a combined overall maximum value of £6528000 which accounts for the tendered cost associated with the maximum volume of doses set out in the tender documentation. Should additional product be required under this contract, the maximum value of combined purchases shall not exceed £6528000.
Reference
- FTS 046961-2026